Wedbush Reiterates Outperform on Jade Biosciences, Maintains $47 Price Target

Benzinga Newsdesk www.benzinga.com Negative 89.5%

Neg 89.5% Neu 0% Pos 0%

Wedbush analyst Laura Chico reiterates Jade Biosciences (NASDAQ:JBIO) with a Outperform and maintains $47 price target.

Comments

No comments yet. Be the first!